R. W. Carlson

A randomized phase III study of iniparib (BSI-201) in combination with gemcitabine/carboplatin (G/C) in metastatic triple-negative breast cancer (TNBC).

J. O’Shaughnessy, Lee S. Schwartzberg, Michael A. Danso et al. · Journal of Clinical Oncology · 2011 · 244 citations

Medicine, Oncology, Pharmacology +16

How well do standard prognostic criteria predict oncotype DX (ODX) scores?

Arif H. Kamal, Charles L. Loprinzi, Christopher A. Reynolds et al. · Journal of Clinical Oncology · 2007 · 16 citations

Medicine, Oncology, Pathology +17

Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation

N. Lynn Henry, Kelly Speth, Anneleen Lintermans et al. · Clinical Breast Cancer · 2017 · 13 citations · Full text

Medicine, Endocrinology, Pharmacology +15

Goserelin plus anastrozole in the treatment of premenopausal hormone receptor positive, recurrent or metastatic breast cancer

R. W. Carlson, Christine M. Schurman, E. Rivera et al. · Journal of Clinical Oncology · 2007 · 11 citations

Medicine, Oncology, Pharmacology +17